adriaticfoto/Shutterstock
Glooko, based in California, and Diasend, based in Sweden, both providers of diabetes management and analytics platforms, have merged.
As a combined entity, the new company now serves 4,000 diabetes clinics in 23 countries across 15 languages, impacting tens of millions of people with diabetes.
The joint platform downloads data from more than 160 different devices, including glucose meters, insulin pumps, continuous glucose monitors (CGMs) and activity trackers, in total covering over 95 percent of diabetes devices used worldwide.
“This is a big day for us – we are thrilled to come together to be able to deliver products and services that will offer even more value to patients and healthcare providers around the world,” said Rick Altinger, chief executive officer (CEO) of Glooko.
Anders Sonesson, CEO of Diasend, said: “This is without a doubt the best possible scenario for our two companies, as well as for patients and the care teams that serve them. From our standpoint, this means adding even more functionality to an already very strong technical platform.”
Glooko, based in California, and Diasend, based in Sweden, which have chosen to unite under the Glooko name, have recently raised $8 million in equity financing, led by global venture capital firm Canaan Partners, to accelerate integration and sales efforts.
Glooko, US, Diasend, Europe, diabetes management, Healthcare, Analytics, M&A, Insurance
